Skip to main content
. 2010 Jan 12;101(4):1067–1071. doi: 10.1111/j.1349-7006.2010.01492.x

Table 2.

 Objective response

S1‐based regimen (31)
S1 alone (5), S1/CDDP (26)
1st line (31) PAC (21)
Weekly PAC (21)
1st line (3), 2nd line (18)
CR 0 0
PR 14 1
SD 11 8
PD 6 12

CDDP, cisplatin; CR, complete response; PAC, paclitaxel; PD, progressive disease; PR, partial response; SD, stable disease.